SG11201506407VA - Kit for tumor imaging - Google Patents
Kit for tumor imagingInfo
- Publication number
- SG11201506407VA SG11201506407VA SG11201506407VA SG11201506407VA SG11201506407VA SG 11201506407V A SG11201506407V A SG 11201506407VA SG 11201506407V A SG11201506407V A SG 11201506407VA SG 11201506407V A SG11201506407V A SG 11201506407VA SG 11201506407V A SG11201506407V A SG 11201506407VA
- Authority
- SG
- Singapore
- Prior art keywords
- kit
- tumor imaging
- tumor
- imaging
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 238000003384 imaging method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361765312P | 2013-02-15 | 2013-02-15 | |
| PCT/US2014/015752 WO2014126902A1 (en) | 2013-02-15 | 2014-02-11 | Kit for tumor imaging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201506407VA true SG11201506407VA (en) | 2015-09-29 |
Family
ID=51354495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201506407VA SG11201506407VA (en) | 2013-02-15 | 2014-02-11 | Kit for tumor imaging |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150374861A1 (en) |
| EP (1) | EP2956157A4 (en) |
| JP (1) | JP2016510342A (en) |
| KR (1) | KR20150140650A (en) |
| CN (1) | CN105377287A (en) |
| AU (1) | AU2014216515A1 (en) |
| CA (1) | CA2901231C (en) |
| SG (1) | SG11201506407VA (en) |
| WO (1) | WO2014126902A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107207379B (en) | 2014-11-25 | 2021-08-10 | 百时美施贵宝公司 | For biological products18Methods and compositions for F-radiolabelling |
| ES2822990T3 (en) | 2014-11-25 | 2021-05-05 | Bristol Myers Squibb Co | Novel PD-L1 Binding Polypeptides for Imaging |
| US10729600B2 (en) | 2015-06-30 | 2020-08-04 | The Procter & Gamble Company | Absorbent structure |
| CN109562195A (en) | 2016-06-01 | 2019-04-02 | 百时美施贵宝公司 | PET imaging is carried out with PD-L1 combination polypeptide |
| US10994033B2 (en) | 2016-06-01 | 2021-05-04 | Bristol-Myers Squibb Company | Imaging methods using 18F-radiolabeled biologics |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985240A (en) * | 1989-08-09 | 1999-11-16 | Rhomed Incorporated | Peptide radiopharmaceutical applications |
| US5112953A (en) * | 1989-12-29 | 1992-05-12 | Neorx Corporation | Radiolabeled proteins for diagnostic or therapeutic use |
| US5961955A (en) * | 1997-06-03 | 1999-10-05 | Coulter Pharmaceutical, Inc. | Radioprotectant for peptides labeled with radioisotope |
| AU8661498A (en) * | 1997-08-01 | 1999-02-22 | Schering Corporation | Mammalian cell membrane proteins; related reagents |
| WO1999051762A1 (en) * | 1998-04-03 | 1999-10-14 | Millennium Pharmaceuticals, Inc. | Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| DE69941708D1 (en) * | 1998-07-20 | 2010-01-07 | Ipsen Pharma | PACAP PEPTIDE ANALOGS |
| JP2003534013A (en) * | 2000-05-24 | 2003-11-18 | シェーリング コーポレイション | Mammalian receptor proteins; related reagents and methods |
| JP2004529884A (en) * | 2001-02-26 | 2004-09-30 | ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー | Ascorbic acid analogs for metal radiopharmaceuticals |
| GB0116815D0 (en) * | 2001-07-10 | 2001-08-29 | Nycomed Amersham Plc | Improved chelator conjugates |
| CA2464002C (en) * | 2001-10-19 | 2011-06-28 | Thomas Jefferson University | Pacap compositions and methods for tumor imaging and therapy |
| EP1444990A1 (en) * | 2003-02-07 | 2004-08-11 | Amersham plc | Improved Radiometal Complex Compositions |
| EP1695089A1 (en) * | 2003-12-15 | 2006-08-30 | Aurelium Biopharma Inc. | Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| CN101293103A (en) * | 2008-06-02 | 2008-10-29 | 北京师范大学 | <99m>TC mark freeze drying article medicinal box and preparation method thereof |
| CN101422623B (en) * | 2008-12-05 | 2010-10-13 | 北京协核吉成科技有限公司 | 99mTc-Trodat-1 marked freeze-dry article medicine-box and preparation method |
-
2014
- 2014-02-11 CN CN201480009211.XA patent/CN105377287A/en active Pending
- 2014-02-11 AU AU2014216515A patent/AU2014216515A1/en not_active Abandoned
- 2014-02-11 SG SG11201506407VA patent/SG11201506407VA/en unknown
- 2014-02-11 CA CA2901231A patent/CA2901231C/en active Active
- 2014-02-11 WO PCT/US2014/015752 patent/WO2014126902A1/en active Application Filing
- 2014-02-11 KR KR1020157025290A patent/KR20150140650A/en not_active Application Discontinuation
- 2014-02-11 US US14/767,927 patent/US20150374861A1/en not_active Abandoned
- 2014-02-11 EP EP14751459.0A patent/EP2956157A4/en not_active Withdrawn
- 2014-02-11 JP JP2015558075A patent/JP2016510342A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150140650A (en) | 2015-12-16 |
| EP2956157A1 (en) | 2015-12-23 |
| JP2016510342A (en) | 2016-04-07 |
| WO2014126902A1 (en) | 2014-08-21 |
| EP2956157A4 (en) | 2017-03-01 |
| CN105377287A (en) | 2016-03-02 |
| CA2901231A1 (en) | 2014-08-21 |
| AU2014216515A1 (en) | 2015-10-08 |
| US20150374861A1 (en) | 2015-12-31 |
| CA2901231C (en) | 2020-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2951642A4 (en) | Omnistereo imaging | |
| IL240271A0 (en) | Multiple-swath stripmap sar imaging | |
| EP3030628A4 (en) | Cyanated naphthalenebenzimidazole compounds | |
| GB201315248D0 (en) | Imaging | |
| EP2948045A4 (en) | Body structure imaging | |
| GB201304149D0 (en) | Ultrasound imaging | |
| HK1213459A1 (en) | Medical imaging | |
| SG11201507801SA (en) | Referencing in multi-acquisition slide imaging | |
| EP2964658A4 (en) | Substituted organofluoroborates as imaging agents | |
| EP2868258A4 (en) | Imaging system | |
| GB2518957B (en) | Imaging apparatus | |
| EP2975408A4 (en) | Examination kit | |
| PL3011321T3 (en) | Coded-aperture x-ray imaging | |
| SG11201506407VA (en) | Kit for tumor imaging | |
| EP2975407A4 (en) | Examination kit | |
| EP2980561A4 (en) | Imaging system | |
| GB201309198D0 (en) | Imaging apparatus | |
| GB201310476D0 (en) | Scintillator | |
| GB2530691B (en) | Radiation imaging | |
| GB2520611B (en) | Image manipulation | |
| TWI559896B (en) | Imaging apparatus | |
| GB2517280B (en) | Coffin | |
| IL245477A0 (en) | Lung cancer diagnosis | |
| GB2512886B (en) | Spectral imaging | |
| SG2013011275A (en) | Imaging solution |